-
National Cancer Institute (NCI) Non-Hodgkin Lymphoma Genome-wide Association Study (GWAS)
Study
phs000801
-
Identifying Novel Small RNA Biomarkers Unique to Patients with Gastric Cancer
Study
phs001767
-
A Phase I Study With a Personalized Neoantigen Cancer Vaccine in Glioblastoma Multiforme
Study
phs001519
-
Enhancer profiling identifies epigenetic markers of endocrine resistance and reveals therapeutic options for metastatic castration-resistant prostate cancer patients (LuCaP cell line data)
Study
EGAS50000000917
-
Development and validation of multivariate predictors of primary endocrine resistance to tamoxifen and aromatase inhibitors in luminal breast cancer reveal drug-specific differences
Study
EGAS50000001102
-
Genome and gene analysis of gastrointestinal cancer and elucidation of its clinicopathological significance
Study
JGAS000233
-
Circulating Tumor DNA in Checkpoint Inhibitor treated Lung Cancer
Study
EGAS00001004847
-
Spiradenocarcinoma
Study
EGAS00001001799
-
Tumor-specific expression of let-7i and miR-192 is associated with resistance to cisplatin-based chemoradiotherapy in patients with larynx and hypopharynx cancer
Study
EGAS00001004001
-
Histone chaperone CHAF1A promotes proliferation and tumorigenicity in gastric cancer and impacts prognosis via context-depedent regulation of gene expression
Study
EGAS00001003064